These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9187898)
21. Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group. Aparicio J; García Del Muro X; Maroto P; Terrasa J; Castellano D; Bastús R; Gumà J; Sagastibeltza N; Durán I; Ochenduszko S; Meana JA; García-Sánchez J; Arranz JA; Gironés R; Germà JR Clin Transl Oncol; 2021 Jan; 23(1):58-64. PubMed ID: 32462393 [TBL] [Abstract][Full Text] [Related]
22. Carboplatin does not prevent contralateral testicular tumors in patients with seminoma. Dieckmann KP; Matthies C; Kliesch S J Clin Oncol; 2011 Jul; 29(21):2944-5; author reply 2945-6. PubMed ID: 21670458 [No Abstract] [Full Text] [Related]
23. Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment alone. Patterson H; Norman AR; Mitra SS; Nicholls J; Fisher C; Dearnaley DP; Horwich A; Mason MD; Huddart RA Radiother Oncol; 2001 Apr; 59(1):5-11. PubMed ID: 11295200 [TBL] [Abstract][Full Text] [Related]
24. Randomized trial of carboplatin versus radiotherapy for stage I seminoma: mature results on relapse and contralateral testis cancer rates in MRC TE19/EORTC 30982 study (ISRCTN27163214). Oliver RT; Mead GM; Rustin GJ; Joffe JK; Aass N; Coleman R; Gabe R; Pollock P; Stenning SP J Clin Oncol; 2011 Mar; 29(8):957-62. PubMed ID: 21282539 [TBL] [Abstract][Full Text] [Related]
25. Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased? Ruf CG; Borck S; Anheuser P; Matthies C; Nestler T; Zecha H; Isbarn H; Dieckmann KP J Cancer Res Clin Oncol; 2019 Sep; 145(9):2335-2342. PubMed ID: 31286241 [TBL] [Abstract][Full Text] [Related]
26. Controversies in the Management of Clinical Stage I Seminoma: Carboplatin a Decade in-Time to Start Backing Out. van de Wetering RAW; Sleijfer S; Feldman DR; Funt SA; Bosl GJ; de Wit R J Clin Oncol; 2018 Mar; 36(9):837-840. PubMed ID: 29389229 [No Abstract] [Full Text] [Related]
27. Myths and facts on adjuvant carboplatin for stage I seminoma. Aparicio J; Germà JR J Clin Oncol; 2006 Jul; 24(21):e40. PubMed ID: 16849740 [No Abstract] [Full Text] [Related]
29. Adjuvant chemotherapy in stage I and stage II testicular cancer. Albers P; Perabo FG; Melchior D; Siener R World J Urol; 2001 Apr; 19(2):76-81. PubMed ID: 11374321 [TBL] [Abstract][Full Text] [Related]
30. Testicular seminoma: Are clinical features and treatment outcomes any different in India? Anjanappa M; Kumar A; Mathews S; Joseph J; Jagathnathkrishna KM; James FV Indian J Cancer; 2017; 54(1):385-387. PubMed ID: 29199728 [TBL] [Abstract][Full Text] [Related]
31. Two cycles of adjuvant carboplatin in stage I seminoma: 8-year experience by the Hellenic Cooperative Oncology Group (HECOG). Koutsoukos K; Tzannis K; Christodoulou C; Karavasilis V; Bakoyiannis C; Makatsoris T; Papandreou CN; Pectasides D; Dimopoulos MA; Bamias A World J Urol; 2016 Jun; 34(6):853-7. PubMed ID: 26410826 [TBL] [Abstract][Full Text] [Related]
32. Use of AUC7 adjuvant carboplatin in patients with stage I seminoma: systematic review of the literature. Siracusano S; Diminutto A; Porcaro AB; Cerruto MA; Artibani W Tumori; 2018; 104(2):83-87. PubMed ID: 27791233 [TBL] [Abstract][Full Text] [Related]
33. A medical research council randomized trial of single agent carboplatin versus etoposide and cisplatin for advanced metastatic seminoma. MRC Testicular Tumour Working Party. Horwich A; Oliver RT; Wilkinson PM; Mead GM; Harland SJ; Cullen MH; Roberts JT; Fossa SD; Dearnaley DP; Lallemand E; Stenning SP; Br J Cancer; 2000 Dec; 83(12):1623-9. PubMed ID: 11104556 [TBL] [Abstract][Full Text] [Related]
34. Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study. Aparicio J; Maroto P; del Muro XG; Gumà J; Sánchez-Muñoz A; Margelí M; Doménech M; Bastús R; Fernández A; López-Brea M; Terrassa J; Meana A; del Prado PM; Sastre J; Satrústegui JJ; Gironés R; Robert L; Germà JR J Clin Oncol; 2011 Dec; 29(35):4677-81. PubMed ID: 22042940 [TBL] [Abstract][Full Text] [Related]
35. Controversies in the management of stage I seminoma: adjuvant carboplatin revisited. Aparicio J; Terrasa J; Clin Transl Oncol; 2019 Feb; 21(2):246-247. PubMed ID: 29992462 [No Abstract] [Full Text] [Related]
36. Neoadjuvant carboplatin before radiotherapy in stage IIA and IIB seminoma. Horwich A; Dearnaley DP; Sohaib A; Pennert K; Huddart RA Ann Oncol; 2013 Aug; 24(8):2104-7. PubMed ID: 23592702 [TBL] [Abstract][Full Text] [Related]
37. Adjuvant carboplatin in stage I seminoma. Warde P; Gospodarowicz M Lancet; 2005 Jul 23-29; 366(9482):267-8. PubMed ID: 16039313 [No Abstract] [Full Text] [Related]
38. Treatment of stage I seminoma: is it time to change your practice? Feldman DR; Bosl GJ J Hematol Oncol; 2008 Nov; 1():22. PubMed ID: 18992162 [TBL] [Abstract][Full Text] [Related]
39. The sword of Damocles and the treatment of stage I seminoma. Oliver T; Mead G; Mason M; Stenning S; Dieckmann K; Steiner H; De Santis M; Aparicio J; Skoneczna I; Kratzik C J Clin Oncol; 2006 Jun; 24(16):2599-600. PubMed ID: 16735720 [No Abstract] [Full Text] [Related]
40. Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: should it be tested in a randomized trial against radiotherapy? Oliver RT; Edmonds PM; Ong JY; Ostrowski MJ; Jackson AW; Baille-Johnson H; Williams MV; Wiltshire CR; Mott T; Pratt WR Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):3-8. PubMed ID: 8175442 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]